We are live on ! Find out more
SGCIA

Smith Graham & Co Investment Advisors Portfolio holdings

AUM $868M
1-Year Est. Return 24.69%
This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+24.69%
3 Year Est. Return
+56.92%
5 Year Est. Return
+190.77%
10 Year Est. Return
+331.98%
AUM
$928M
AUM Growth
+$17.7M
Cap. Flow
-$5.25M
Cap. Flow %
-0.57%
Top 10 Hldgs %
13.34%
Holding
134
New
3
Increased
22
Reduced
107
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 21.12%
2 Technology 20.17%
3 Industrials 18.32%
4 Consumer Discretionary 16.82%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GT icon
126
Goodyear
GT
$1.85B
$3.79M 0.41%
247,624
-10,800
-4% -$182K
SRE icon
127
Sempra
SRE
$54.8B
$3.52M 0.38%
51,240
-2,220
-4% -$146K
AEE icon
128
Ameren
AEE
$30.1B
$3.49M 0.38%
46,430
-1,940
-4% -$143K
STZ icon
129
Constellation Brands
STZ
$23.2B
$3.41M 0.37%
17,308
-680
-4% -$133K
ACH
130
Accendra Health
ACH
$214M
$2.57M 0.28%
804,405
-1,970
-0.2% -$6.72K
DF
131
DELISTED
Dean Foods Company
DF
$1.98M 0.21%
2,147,800
+280,880
+15% +$452K
WCG
132
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.57M 0.17%
5,512
-19,560
-78% -$5.39M
TSS
133
DELISTED
Total System Services, Inc.
TSS
-63,220
Closed -$6.01M
EFII
134
DELISTED
Electronics for Imaging
EFII
-323,376
Closed -$8.7M

Similar funds

Smith Graham & Co Investment Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Smith Graham & Co Investment Advisors held 134 positions worth $928M, up 1.9% from $910M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 3.7%. Smith Graham & Co Investment Advisors opened 3 new positions and exited 2, leaving the 134-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Smith Graham & Co Investment Advisors's largest Q2 2019 buy was Hibbett, Inc. Common Stock: 451,416 shares worth $8.22M.
  • Smith Graham & Co Investment Advisors added most to Eagle Pharmaceuticals, Inc. in Q2 2019, an estimated $3.38M increase.
  • Smith Graham & Co Investment Advisors's biggest Q2 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $5.39M.
  • Smith Graham & Co Investment Advisors fully exited Electronics for Imaging in Q2 2019, selling an estimated $8.7M.
  • Smith Graham & Co Investment Advisors's ten largest holdings make up 13% of its $928M portfolio in Q2 2019.
  • Smith Graham & Co Investment Advisors opened 3 new positions and closed 2 in Q2 2019.
  • Smith Graham & Co Investment Advisors's portfolio value rose 1.9% quarter-over-quarter to $928M.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.